Slowing Friedreich Ataxia Progression with Omaveloxolone: How It Works │PHARMACOLOGY скачать в хорошем качестве

Slowing Friedreich Ataxia Progression with Omaveloxolone: How It Works │PHARMACOLOGY

Omaveloxolone (Skyclarys ™), is used for the treatment of Friedreich ataxia in adults and children 16 years of age and older. Friedreich’s ataxia (FA) is a rare, inherited, degenerative disease that damages the nervous system. In this video, you will learn about omaveloxolone’s mechanism of action and the clinical trial results that led to its FDA approval. Disclaimer: This YouTube channel is not intended to provide diagnosis, treatment, or medical advice. The content provided in this video is for informational purposes only. This should not be considered as a substitute for healthcare professional advice. Please consult a physician or other healthcare professional regarding any medical or health-related diagnosis or treatment options. The statements about specific products are not to diagnose, treat, cure, or prevent disease. References: 1. Williams CT, De Jesus O. Friedreich Ataxia. 2023 Aug 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 33085346. 2. https://www.fda.gov/drugs/news-events... 3. Lee A. Omaveloxolone: First Approval. Drugs. 2023 Jun;83(8):725-729. doi: 10.1007/s40265-023-01874-9. PMID: 37155124. 4. Dayalan Naidu S, Dinkova-Kostova AT. Omaveloxolone (SkyclarysTM) for patients with Friedreich's ataxia. Trends Pharmacol Sci. 2023 Jun;44(6):394-395. doi: 10.1016/j.tips.2023.03.005. Epub 2023 May 2. PMID: 37142519. 5. Pilotto F, Chellapandi DM, Puccio H. Omaveloxolone: a groundbreaking milestone as the first FDA-approved drug for Friedreich ataxia. Trends Mol Med. 2024 Feb;30(2):117-125. doi: 10.1016/j.molmed.2023.12.002. Epub 2024 Jan 24. PMID: 38272714. 6. https://www.skyclarys.com/en-us/home/... #FriedreichsAtaxia #Omaveloxolone #RareDisease #NeurodegenerativeDisease #FriedreichsAtaxiaTreatment #FriedreichsAtaxiaResearch #OmaveloxoloneClinicalTrials #NeurologicalDisorders #GeneticDisorders #MedicalEducation #PharmacyEducation